The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted

Current Biology

Volumn 8, Issue 9, 1998, Pages 516-524

  Brown, Ken ^a   Strathdee, Douglas ^a,b   Bryson, Sheila ^a   Lambie, Wendy ^a   Balmain, Allan ^a,c  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ONYX PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; MUS MUSCULUS;

EID: 0032559976     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(98)70203-9     Document Type: Article

References (44)

1. Cairns J: Mutation selection and the natural history of cancer. Nature 1975, 255:197-200.
2. Barrandon Y, Morgan JR, Mulligan RC, Green H: Restoration of growth potential in paraclones of human keratinocytes by a viral oncogene. Proc Natl Acad Sci USA 1989, 86:4102-4106.
3. Greaves MF: Differentiation-linked leukemogenesis in lymphocytes. Science 1986, 234:697-704.
4. Hecker E, Fusenig NE, Kunz W, Marks F, Thielmann HW: Carcinogenesis. A Comprehensive Survey. Volume 7; Cocarcinogenesis and Biological Effects of Tumor Promoters. New York: Raven Press; 1982.
5. Van Duuren BL, Sivak A, Katz C, Seidman I, Melchionine S: The effect of aging and interval between primary and secondary treatment in two stage carcinogenesis in mouse skin. Cancer Res 1975, 35:502-505.
6. Rotten CS: The epidermal proliferative unit: the possible role of the central basal cell. Cell Tissue Kinet 1974, 7:77-88.
7. Mackenzie IC, Fusenig NE: Regeneration of organized epithelial structure. J Invest Dermatol 1983, 81 (Suppl):189S-194S.
8. Jones PH, Harper S, Watt FM: Stem cell patterning and fate in human epidermis. Cell 1995, 80:83-93.
9. Sun TT, Cotsarelis G, Lavker RM: Hair follicular stem cells: the bulge-activation hypothesis. J Invest Dermatol 1991, 96(Suppl):77S-78S.
10. Rochat A, Kobayashi K, Barrandon Y: Location of stem cells of human hair follicles by clonal analysis. Cell 1994, 76:1063-1073.
11. Miller SJ, Wei Z, Wilson C, Dzubow L, Sun T, Lavker RM: Mouse skin is particularly susceptible to tumor initiation during early anagen of the hair cycle: possible involvement of hair follicle stem cells. J Invest Dermatol 1993, 101:591-594.
12. Scribner JD, Scribner NK, McKnight B, Mottet NK: Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz(a)anthracene. Cancer Res 1983, 43:2034-2041.
13. Brown K, Buchmann A, Balmain A: Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumour progression. Proc Natl Acad Sci USA 1990, 87:538-542.
14. Hennings H, Shores R, Mitchell P, Spangler EF, Yuspa SH: Induction of papillomas with a high probability of conversion to malignancy. Carcinogenesis 1985, 6:1607-1610.
15. Glick AB, Kulkarni AB, Tennenbaum T, Hennings H, Flanders KC, O'Reilly M, et al.: Loss of TGF-β expression in mouse epidermis and epidermal tumors is associated with hyperproliferation and a high risk for malignant conversion. Proc Natl Acad Sci USA 1993, 90:6076-6080.
16. null mice is prognostic for a high risk of malignant conversion. Cancer Res 1994, 54:5831-5836.
17. Tennenbaum T, Yuspa SH, Grover A, Castronovo V, Sobel ME, Yamada Y, et al.: Extracellular matrix receptors and mouse skin carcinogenesis: altered expression linked to appearance of early markers of tumor progression. Cancer Res 1992, 52:2966-2976.
18. Nischt R, Roop DR, Mehrel T, Yuspa SH, Rentrop M, Winter H, et al.: Aberrant expression during two-stage mouse skin carcinogenesis of a type I 47-kDa keratin, K13, normally associated with terminal differentiation of internal stratified epithelia. Mol Carcinogen 1988, 1:96-108.
19. Quintanilla M, Brown K, Ramsden M, Balmain A: Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 1986, 322:78-80.
20. Bailleul B, Surani MA, White S, Barton SC, Brown K, Blessing M, et al.: Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter. Cell 1990, 62:697-708.
21. Schweizer J, Kinjo M, Furstenberger G, Winter H: Sequential expression of mRNA-encoded keratin sets in neonatal mouse epidermis: basal cells with properties of terminally differentiating cells. Cell 1984, 37:159-170.
22. Greenhalgh DA, Rothnagel JA, Quintanilla MI, Orengo CC, Gagne TA, Bundman DS, et al.: Induction of epidermal hyperplasia, hyperkeratosis, and papillomas in transgenic mice by a targeted v-Ha-ras oncogene. Mol Carcinogen 1993, 7:99-110.
23. Casatorres J, Navarro JM, Blessing M, Jorcano JL: Analysis of the control of expression and tissue specificity of the keratin 5 gene, characteristics of basal keratinocytes. J Biol Chem 1994, 269:20489-20496.
24. Byrne C, Fuchs E: Probing keratinocyte and differentiation specificity of the human K5 promoter in vitro and in transgenic mice. Mol Cell Biol 1993, 13:3176-3190.
25. Ramirez A, Bravo A, Jorcano JL, Vidai M: Sequences 5′ of the bovine keratin 5 gene direct tissue- and cell-type-specific expression of a lacZ gene in the adult and during development. Differentiation 1994, 58:53-64.
26. Ghadially FH: The role of the hair follicle in the origin and evolution of some cutaneous neoplasms of man and experimental animals. Cancer 1961,14:801-816.
27. Cano A, Gamallo C, Kemp CJ, Benito N, Palacios J, Quintanilla M, et al.: The expression pattern of the cell adhesion molecules E-cadherin, P-cadherin and a6b4 integrin is altered in premalignant skin tumours of p53-deficient mice, Int J Cancer 1996, 65:254-262.
28. Greenhalgh DA, Wang X, Dominey AM, Rothnagel JA, Roop DR: Transgenic mouse models for skin carcinogenesis. In Skin Cancer: Mechanisms and Human Relevance. Edited by Mukhtar H. Boca Raton: CRC Press, Inc; 1995:317-330.
29. Brown K, Quintanilla M, Ramsden M, Kerr IB, Young S, Balmain A: v-ras genes from Harvey and BALB murine sarcoma viruses can act as initiators of two-stage mouse skin carcinogenesis. Cell 1986, 46:447-456.
30. Roop DR, Lowy DR, Tambourin PE, Strickland J, Harper JR, Balaschak M, et al.: An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue. Nature 1986, 323:822-824.
31. Traverse S, Gomez N, Paterson H, Marshall C, Cohen P: Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem J 1992, 288:351-355.
32. Som T, Klaparthi VSR: Developmental decisions in Aspergillus nidulans are modulated by ras activity. Mol Cell Biol 1994, 14:5333-5348.
33. Missero C, Serra C, Stenn K, Dotto GP: Skin-specific expression of a truncated E1a oncoprotein binding to P105-Rb leads to abnormal hair follicle maturation without increased epidermal proliferation. J Cell Biol 1993, 121:1109-1120.
34. Battalora MSJ, Conti CJ, Aldaz CM, Slaga TJ, Johnston DA, DiGiovanni J: Regression and progression characteristics of papillomas induced by chryserobin in SENCAR mice. Carcinogenesis 1996, 17:955-960.
35. Hansen LA, Tennant RW: Follicular origin of epidermal papillomas in v-Ha-ras transgenic TG.AC mouse skin. Proc Natl Acad Sci USA 1994, 91:7822-7826.
36. Argyris TS, Slaga TJ: Promotion of carcinomas by repeated abrasion in initiated skin of mice. Cancer Res 1981, 41:5193-5195.
37. O'Brien TG, Megosh LC, Gilliard G, Soler AP: Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin. Cancer Res 1997, 57:2630-2637.
38. Morris RJ, Fischer SM, Slaga TJ: Evidence that a slowly cycling subpopulation of adult murine epidermal cells retains carcinogen. Cancer Res 1986, 46:3061-3066.
39. Mulligan RC, Howard BH, Berg P: Synthesis of rabbit β-globin in cultured monkey kidney cells following infection with a SV40 β-globin recombinant genome. Nature 1979, 277:108-114.
40. Hogan B, Beddington R, Constantini F, Lacy E: Manipulating the Mouse Embryo, 2nd edn. New York: Cold Spring Harbour Laboratory Press; 1994.
41. Laird PW, Zijderveld A, Linders K, Rudnicki MA, Jaenisch R, Berns A: Simplified mammalian DNA isolation procedure. Nucleic Acids Res 1991, 19:4293.
42. Walter CA, Nasr-Schirf D, Luna VJ: Identification of transgenic mice carrying the CAT gene with PCR amplification. Cancer Res 1989, 7:1065-1070.
43. Furth ME, Davis LJ, Fleurdelys B, Scolnick EM: Monoclonal antibodies to the P21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family. J Virol 1982, 43:294-304.
44. Cui W, Fowlis DJ, Cousins FM, Duffie E, Bryson S, Balmain A, et al.: Concerted action of the TGF-β1 and its type II receptor in control of epidermal homoeostasis in transgenic mice. Genes Dev 1995, 9:945-955.